The effects of vardenafil and pentoxifylline administration in an animal model of ischemic colitis

Clinics

Volumn 69, Issue 11, 2014, Pages 763-769

  Aziret, Mehmet ^a   Irkorucu, Oktay ^b   Reyhan, Enver ^b   Erdem, Hasan ^b   Das, Koray ^b   Ozkara, Selvinaz ^c   Surmelioglu, Ali ^c   Sozen, Selim ^d   Bali, Ilhan ^d   Cetinkunar, Sulleyman ^b   Deger, Kamuran Cumhur ^b  

^a Kars State Hospital   (Turkey)

^b Numune Training and Research Hospital   (Turkey)

^c GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^d NAMIK KEMAL UNIVERSITY   (Turkey)

Author keywords

Ischemic colitis; PDE 5 inhibitors; Pentoxifylline; Vardenafil

Indexed keywords

IMIDAZOLE DERIVATIVE; MALONALDEHYDE; PENTOXIFYLLINE; PHOSPHODIESTERASE V INHIBITOR; PIPERAZINE DERIVATIVE; SULFONE; TRIAZINE DERIVATIVE; VARDENAFIL;

ANIMAL; COLITIS, ISCHEMIC; COLON; DISEASE MODEL; DRUG EFFECTS; FEMALE; HEMODYNAMICS; PATHOLOGY; RANDOMIZATION; REPRODUCIBILITY; TIME; TREATMENT OUTCOME; WISTAR RAT;

ANIMALS; COLITIS, ISCHEMIC; COLON; DISEASE MODELS, ANIMAL; FEMALE; HEMODYNAMICS; IMIDAZOLES; MALONDIALDEHYDE; PENTOXIFYLLINE; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; RANDOM ALLOCATION; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; SULFONES; TIME FACTORS; TREATMENT OUTCOME; TRIAZINES; VARDENAFIL DIHYDROCHLORIDE;

EID: 84920432204     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2014(11)10     Document Type: Article

References (39)

1. Greenwald DA, Brandt LJ, Reinus JF. Ischemic bowel disease in the elderly. Gastroenterol Clin North Am. 2001;30:445–73, http://dx.doi.org/10.1016/S0889-8553(05)70190-4.
2. Elder K, Lashner BA, Al Solaiman F. Clinical approach to colonic ischemia. Cleve Clin J Med. 2009:76(7):401–9, http://dx.doi.org/10.3949/ccjm.76a.08089.
3. Boley SJ, Brandt LJ, Sammartano RJ. History of mesenteric ischemia. The evolution of a diagnosis and management. Surg Clin North Am. 1997;77(2):275-88, http://dx.doi.org/10.1016/S0039-6109(05)70548-X.
4. Longo WE, Ward D, Vernava 3rd AM, Kaminski DL. Outcome of patients with total colonic ischemia. Dis Colon Rectum. 1997;40(12):1448-54, http://dx.doi.org/10.1007/BF02070711.
5. Brandt LJ, Smithline AE. Ischemic lesions of the bowel. In: Feldman M, Scharschmidt BF, Sleisenger MH, eds. Gastrointestinal and Liver Disease. 6th edn. WB Saunders: Philadelphia, 1998:2009–24.
6. Cappell MS. Intestinal (mesenteric) vasculopathy. II. Ischemic colitis and chronic mesenteric ischemia. Gastroenterol Clin North Am. 1998;27(4):827-60, vi, http://dx.doi.org/10.1016/S0889-8553(05)70034-0.
7. Diaz Nieto R, Varcada M, Ogunbiyi OA, Winslet MC. Systematic review on the treatment of ischaemic colitis. Colorectal Dis. 2011;13(7):744-7, http://dx.doi.org/10.1111/j.1463-1318.2010.02272.x.
8. Reissfelder C, Sweiti H, Antolovic D, Rahbari NN, Hofer S, Büchler MW, et al. Ischemic colitis: who will survive? Surgery. 2011;149(4):585-92, http://dx.doi.org/10.1016/j.surg.2010.11.008.
9. Irkorucu O, Taşcilar O, Cakmak GK, Karakaya K, Emre AU, Ucan BH, et al. The effect of sildenafil on an animal model for ischemic colitis Dig Dis Sci. 2008;53(6):1618-23.
10. Stoop MJ, Dirksen R, Hendriks T. Advanced age alone does not suppress anastomotic healing in intestine. Surgery. 1996;119(1):15-9, http://dx.doi.org/10.1016/S0039-6060(96)80207-8.
11. Griffen TS, Hagihara PF. Ischemic colitis in rats. Dis Colon Rectum. 1982;25(7):638-40, http://dx.doi.org/10.1007/BF02629530.
12. Gomella LG, Flanigan GC, Hagihara PF, Lucas BA, McRoberts JW. The influence of uremia and immunosuppression on an animal model for ischemic colitis. Dis Colon Rectum. 1986;29(11):724-7, http://dx.doi.org/10.1007/BF02555319.
13. Wallace JL, Keenan CM. An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. Am Am J Physiol. 1990;258(4 Pt 1):G527-34.
14. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg. 1970;101(4):478-83.
15. Uchiyama M, Mihara M. Determination of malonaldehyde precurser in tissues by thiobarbituric acid test. Anal Biochem. 1978;86(1):271-8, http://dx.doi.org/10.1016/0003-2697(78)90342-1.
16. Balthazar EJ, Yen BC, Gordon RB. Ischemic colitis: CT evaluation of 54 cases. Radiology. 1999;211(2):381-8, http://dx.doi.org/10.1148/radiology.211.2.r99ma28381.
17. Medina C, Vilaseca J, Videla S, Farba R, Armengol-Miro JR, Malagelada JR. Outcome of patients with ischemic colitis: review of fifty-three cases. Dis Colon Rectum. 2004;47(2):180-4, http://dx.doi.org/10.1007/s10350-003-0033-6.
18. Sreenarasimhaiah J. Diagnosis and management of ischemic colitis. Curr Gastroenterol Rep. 2005;7(5):421-6, http://dx.doi.org/10.1007/s11894-005-0013-1.
19. Korotinski S, Katz A, Malnick SD. Chronic ischaemic bowel disease in the aged-go with the flow. Age Ageing. 2005;34(1):10-6, http://dx.doi.org/10.1093/ageing/afh226.
20. Longo WE, Ballantyne GH, Gusberg RJ. Ischemic colitis: Patterns and prognosis. Dis Colon Rectum. 1992;35(8):726-30, http://dx.doi.org/10.1007/BF02050319.
21. Mishima Y, Horie Y. Experimental studies of ischemic enterocolitis. World J Surg. 1980;4:601–8.
22. Fan YF, Zhang R, Jiang X, Wu DC, Liu D, Yuan P, et al. The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension. Cardiovasc Res. 2013;99(3):395-403, http://dx.doi.org/10.1093/cvr/cvt109.
23. Sotiriadis J, Brandt LJ, Behin DS, Southern WN. Ischemic colitis has a worse prognosis when isolated to the right side of the colon. Am J Gastroenterol. 2007;102(10):2247-52.
24. Hotta Y, Ohno R, Kataoka T, Mikumo M, Takahata Y, Ohno M, et al. Effects of chronic vardenafil treatment persist after end of treatment in rats with acute arteriogenic erectile dysfunction. J Sex Med. 2012;9(7):1782–8.
25. Parra-Membrives P, Ruiz-Luque V. Effect of Pentoxifylline on the Healing of ischemic colorectal anastomoses. Dis Colon Rectum. 2006; 50(3):369–75.
26. Tireli GA, Salman T. The effect of pentoxifylline on intestinal anastomotic healing after ischemia. Pediatr Surg Int. 2003;19(1-2):88-90.
27. El-Awady MS, Said E. Vardenafil ameliorates immunologic- and nonimmunologic- induced allergic reactions. Can J Physiol Pharmacol. 2014;92(3):175-80, http://dx.doi.org/10.1139/cjpp-2013-0316.
28. Sarifakioglu N, Gokrem S, Ates L, Akbuga UB, Aslan G. The influence of sildenafil on random skin flap survival in rats: an experimental study. Br J Plast Surg. 2004;57(8):769-72.
29. Hart K, Baur D, Hodam J, Lesoon-Wood L, Parham M, Keith K et al. Short- and long-term effects of sildenafil on skin flap survival in rats. Laryngoscope. 2006;116(4):522-8, http://dx.doi.org/10.1097/01.mlg.0000200792.67802.3b.
30. Chen WS, Li XQ, Cao W, Xiao X, Dong L, Zhang JZ. Vardenafil ameliorates calcium mobilization in pulmonary artery smooth muscle cells from hypoxic pulmonary hypertensive mice. Arch Med Res. 2012;43(4):265-73, http://dx.doi.org/10.1016/j.arcmed.2012.05.004.
31. Martínez-Salamanca JI, La Fuente JM, Cardoso J, Fernández A, Cuevas P, Wright HM, et al. Nebivolol potentiates the efficacy of PDE5 inhibitors to relax corpus cavernosum and penile arteries from diabetic patients by enhancing the NO/cGMP pathway. J Sex Med. 2014;11(5):1182-92.
32. Dogrell SA. Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction. Expert Opin Pharmacother. 2005;6(1):75-84, http://dx.doi.org/10.1517/14656566.6.1.75.
33. Rasslan R, Utiyama EM, Marques GM, Ferreira TC, Costa VA, Victo NC, et al. Inflammatory activity modulation by hypertonic saline and pentoxifylline in a rat model of strangulated closed loop small bowel obstruction. Int J Surg. 2014;12(6):594-600.
34. Ersoy YE, Ayan F, Himmetoglu S. Trace element levels in ischemiareperfusion injury after left colonic anastomosis in rats and effects of papaverine and pentoxiphylline on vascular endothelial growth factor in anastomosis healing. Acta Gastroenterol Belg. 2011;74(1):22-7.
35. Sunil VR, Vayas KN, Cervelli JA, Malaviya R, Hall L, Massa CB, et al. Pentoxifylline attenuates nitrogen mustard-induced acute lung injury, oxidative stress and inflammation. Exp Mol Pathol. 2014;97(1):89-98, http://dx.doi.org/10.1016/j.yexmp.2014.05.009.
36. Kyriazis I, Kagadis GC, Kallidonis P, Georgiopoulos I, Marazioti A, Geronasiou A, et al. PDE5 inhibition against acute renal ischemia reperfusion injury in rats: does vardenafil offer protection? World J Urol. 2013;31(3):597-602.
37. Minareci E and Sadan G. An evaluation of vardenafil as a calcium channel blocker in pulmonary artery in rats. Indian J Pharmacol. 2014;46(2):185-90.
38. Fang L, Radovits T, Szabo G, Mozes MM, Rosivall L, Kokeny G. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 39,59 guanosine monophosphate (cGMP) level in podocytes. Nephrol Dial Transplant. 2013;28(7):1751-61, http://dx.doi.org/10.1093/ndt/gfs391.
39. Veres G, Hegedűs P, Barnucz E, Zöller R, Radovits T, Korkmaz S, et al. Addition of vardenafil into storage solution protects the endothelium in a hypoxia-reoxygenation model. Eur J Vasc Endovasc Surg. 2013;46(2):242-8, http://dx.doi.org/10.1016/j.ejvs.2013.05.006.